Cas:1292324-51-6 2-Methyl-2-propanyl (3S)-tetrahydro-3-furanylcarbamate manufacturer & supplier

We serve Chemical Name:2-Methyl-2-propanyl (3S)-tetrahydro-3-furanylcarbamate CAS:1292324-51-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-Methyl-2-propanyl (3S)-tetrahydro-3-furanylcarbamate

Chemical Name:2-Methyl-2-propanyl (3S)-tetrahydro-3-furanylcarbamate
CAS.NO:1292324-51-6
Synonyms:Carbamic acid, N-[(3S)-tetrahydro-3-furanyl]-, 1,1-dimethylethyl ester;2-Methyl-2-propanyl (3S)-tetrahydro-3-furanylcarbamate
Molecular Formula:C9H17NO3
Molecular Weight:187.236
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:282.9±29.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.464
PSA:51.05000
Exact Mass:187.120850
LogP:0.89

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Carbamic acid, N-[(3S)-tetrahydro-3-furanyl]-, 1,1-dimethylethyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Methyl-2-propanyl (3S)-tetrahydro-3-furanylcarbamate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Carbamic acid, N-[(3S)-tetrahydro-3-furanyl]-, 1,1-dimethylethyl ester Use and application,2-Methyl-2-propanyl (3S)-tetrahydro-3-furanylcarbamate technical grade,usp/ep/jp grade.


Related News: India and China are two of the leading players in that game, and US legislators for months have pushed for an aggressive “onshoring” of drug production to counteract the nation’s reliance on foreign producers. Israel, a key ally to the US, could be a logical partner in that effort, but the Trump administration also took out big bets on US firms to set up shop stateside. 5-tert-butyl-2-methoxy-3-nitrobenzaldehyde manufacturers ChenMed, which presently operates more than 80 Chen, Dedicated and JenCare Senior Medical Centers in 12 states, has successfully vaccinated 100 percent of doctors and staff at over 70 of its practices by educating and encouraging care team members and patients alike through its ongoing and multifaceted VaxTheNation® initiative. (4S,4aR,5S,6R,7aS,7bS)-6-[((1,1-dimethylethyl)siloxy)methyl]-(5-phenylmethoxy)-4,4a,5,6,7a,7b-hexahydro-2H-1,7-dioxacyclopent[cd]indene-4-ol benzoate suppliers Despite the $13 million first-quarter hit from the rate cut, iRhythm grew revenue year over year by 17% to $74.3 million in the quarter. iRhythm’s net losses for the quarter totaled $27.8 million, compared to a net loss of $9.1 million in the first quarter of 2020. 2,3-dibromo-3-(2-chloro-phenyl)-1-(2,4-dihydroxy-phenyl)-propan-1-one vendor & factory.